share_log

榮昌生物:海外監管公告 - 關於本次向特定對象發行A股股票不會直接或通過利益相關方向參與認購的投資者提供財務資助或補償的公告

REMEGEN: An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section

香港交易所 ·  Apr 2 00:28
Summary by Moomoo AI
荣昌生物(煙台)股份有限公司(「荣昌生物」)於2024年3月29日召開董事會及監事會會議,審議通過了關於2024年度向特定對象發行A股股票的相關議案。公司明確表示,在本次特定對象發行股票過程中,不存在向發行對象做出保底保收益或變相保底保收益的承諾,也沒有直接或通過利益相關方向參與認購的投資者提供財務資助或補償的情形。該聲明旨在確保發行過程的透明度和公平性,並由董事會全體成員對公告內容的真實性、準確性和完整性承擔法律責任。公告於2024年3月30日由董事會發布。
荣昌生物(煙台)股份有限公司(「荣昌生物」)於2024年3月29日召開董事會及監事會會議,審議通過了關於2024年度向特定對象發行A股股票的相關議案。公司明確表示,在本次特定對象發行股票過程中,不存在向發行對象做出保底保收益或變相保底保收益的承諾,也沒有直接或通過利益相關方向參與認購的投資者提供財務資助或補償的情形。該聲明旨在確保發行過程的透明度和公平性,並由董事會全體成員對公告內容的真實性、準確性和完整性承擔法律責任。公告於2024年3月30日由董事會發布。
RONG CHANG BIO (YANTAI) CO., LTD. (“RONG CHANG BIO”) HELD A MEETING OF THE BOARD OF DIRECTORS AND SUPERVISORY BOARD ON 29 MARCH 2024 TO CONSIDER THE ADOPTION OF THE RELEVANT MOTIONS REGARDING THE ISSUANCE OF A SHARES TO SPECIFIC OBJECTS IN 2024. The Company expressly states that during this particular issuer share issuance process, there was no commitment to underwritten or variable hedged income to the issuer, nor was there any provision of financial support or compensation to investors participating in the subscription directly or through interest-related directions. The statement is intended to ensure transparency and fairness of the issuance process and all members of the Board are legally responsible for the truthfulness, accuracy and completeness of the contents of the announcement. Announcement to be issued by the Board of Directors on 30 March 2024.
RONG CHANG BIO (YANTAI) CO., LTD. (“RONG CHANG BIO”) HELD A MEETING OF THE BOARD OF DIRECTORS AND SUPERVISORY BOARD ON 29 MARCH 2024 TO CONSIDER THE ADOPTION OF THE RELEVANT MOTIONS REGARDING THE ISSUANCE OF A SHARES TO SPECIFIC OBJECTS IN 2024. The Company expressly states that during this particular issuer share issuance process, there was no commitment to underwritten or variable hedged income to the issuer, nor was there any provision of financial support or compensation to investors participating in the subscription directly or through interest-related directions. The statement is intended to ensure transparency and fairness of the issuance process and all members of the Board are legally responsible for the truthfulness, accuracy and completeness of the contents of the announcement. Announcement to be issued by the Board of Directors on 30 March 2024.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more